European Pharmaceutical Review podcast

Jun 25 2024 26 ep. 25 mins 8
European Pharmaceutical Review podcast artwork

European Pharmaceutical Review’s podcasts interview some of the leading experts and scientists about the latest developments in the pharmaceutical and life science sectors.

  Science  Health & Fitness
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


EPR Podcast Episode 26 – Navigating Nitrosamine Impurities – Jason Brown, Adare Pharma Solutions

Jun 25 2024 31 mins  
In this podcast, Jason Brown, Senior Manager, Analytical Sciences, R&D, Adare Pharma Solutions, discusses the current landscape and the best approaches for mitigating contamination and detecting nitrosamines.

EPR Podcast 25 – FAIR Data in Pharma – Giovanni Nisato, Pistoia Alliance

May 29 2024 29 mins  
In this podcast, Giovanni Nisato, Project Manager at the Pistoia Alliance discusses data integrity and the progress towards implementation of FAIR data principles in the pharmaceutical industry.

EPR Podcast 24 – Developing modifier gene therapy – Ocugen

Apr 30 2024 29 mins  
Ocugen is utilising the modifier gene therapy technology approach to treat retinal diseases. The therapy can be used to treat both inherited disorders, such as retinitis pigmentosa (RP), Leber congenital amaurosis, and Stargardt disease, but also multifactorial diseases like dry age-related macular degeneration and angiographic atrophy. The company’s lead candidate in modifier g

EPR Podcast 23 – Inspiring inclusion in pharma – Kylie Bromley, Biogen

Feb 27 2024 29 mins  
In this podcast, recorded ahead of International Women’s Day, Biogen’s Dr Kylie Bromley reflects on her career in the pharmaceutical sector and shares valuable insight into how the industry can work together to build greater gender equality and diversity.

EPR Podcast 22 – Pharmaceutical packaging – Manu Kittanakere, Gilead

Jan 31 2024 25 mins  
In this podcast, Manu Kittanakere, Associate Director of Packaging Engineering at Gilead discusses the future of pharmaceutical packaging, including the growing importance of AI, automation and sustainability in packaging engineering.

EPR Podcast Episode 21 – Biosimilars – Salim Benkhalifa, Celltrion Healthcare France

Dec 05 2023 20 mins  
In this episode, Dr Salim Benkhalifa, Medical Affairs Lead, Celltrion Healthcare France reflects on biosimilars development, highlighting the three core challenges facing the sector and how they might be overcome.

EPR Podcast 20 – RNAi Therapeutics – Paul Nioi, Alnylam Pharmaceuticals

Aug 08 2023 21 mins  
In this podcast, Paul Nioi, Vice President of Discovery and Translational Research at Alnylam Pharmaceuticals discusses the clinical development and manufacturing of RNA interference (RNAi) therapeutics. RNA interference (RNAi) medicines that can ‘silence’ or turn off the production of specific genes that cause or contribute to disease, are one of the exciting emerging modalit

EPR Podcast 19 – Collaboration in microbiology – Allison Scott, Lynn Johnson and Miriam Guest, M³ Collaboration

May 30 2023 25 mins  
In this podcast, Allison Scott, Lynn Johnson and Miriam Guest of the Modern Microbial Methods Collaboration discuss how cross-industry collaboration through working groups can support adoption of modern microbial methods.

EPR Podcast Episode 18 – Embracing continuous manufacturing – Trish Hurter, Lyndra Therapeutics

Mar 13 2023 27 mins  
Continuous manufacturing (CM) is recognised industry wide as a more efficient and flexible manufacturing approach than batch manufacturing. Yet, despite encouragement from regulators and being standard in many industries, the pharmaceutical sector has been quite slow to adopt continuous manufacturing techniques. In this episode, Patricia Hurter, CEO of Lyndra Therapeutics, discuss

EPR Podcast Episode 17 – Antimicrobial Resistance – Boumediene Soufi, Sandoz

Nov 23 2022 29 mins  
Antimicrobial resistance (AMR) is a growing concern worldwide and is recognised as one of the leading health challenges by the World Health Organization (WHO). With drug resistant infections contributing to nearly 5 million deaths every year and costing the European Union (EU) an estimated €1.5 billion per year in healthcare costs and productivity losses, AMR is both a scientific